Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-005776
Filing Date
2024-08-01
Accepted
2024-08-01 16:34:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4994
  Complete submission text file 0001950047-24-005776.txt   6458
Mailing Address
Business Address
KARABELAS ARGERIS N (Reporting) CIK: 0001191229 (see all company filings)

Type: 144

Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Subject) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37553 | Film No.: 241167326
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)